Actually that is not true. Any valuation company looking to price Elite at fair value would value Elite's generic OxyContin, percocet and norco products currently prior to approval at way more than the existing generic pipeline. True the price value would increase after approval but value is still determined even with products not yet launched.
News 
Market Data 
Discover 
